The Seven Trial: Exploiting the Unfolded Protein Response

The Seven Trial: Exploiting the Unfolded Protein Response

Conditions: Pancreatic Cancer Metastatic; Pancreatic Adenocarcinoma Metastatic
Interventions: Drug: Botensilimab; Drug: Balstilimab; Drug: Chloroquine Phosphate; Drug: Celecoxib
Sponsors: HonorHealth Research Institute; Translational Genomics Research Institute; University of Arizona; Agenus Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 12, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments